PPIA and metabolic dysfunction-associated steatohepatitis: It is even possible that the DNA repair phenotypes we’ve described here following CYPA PPI inhibition could contribute to the efficacy of NIAs in the context of inflammatory conditions such as fibrosis and non-alcoholic steatohepatitis, through the elimination of key relevant cell-types.